Document Detail


Inhibition of B16 melanoma metastasis by the immunomodulator AS101.
MedLine Citation:
PMID:  21541518     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The immunomodulator ammonium trichloro (dioxyethylene-O-O')tellurate (AS101) has previously been found to induce secretion of various cytokines in mouse and human, which include interleukin-l, interleukin-2, colony-stimulating factor, interferon-gamma, tumor necrosis factor, etc. It also protects mice from lethal and sublethal effects of chemotherapy and irradiation. The present studies were designed to evaluate its effect on pulmonary metastasis following intravenous (i.v.) injection of mouse B16 melanoma cells on day 0 of the experiment. AS101, given 10 mu g/mouse intraperitoneally in 7 daily injections starting the day before B16 cell infusion (day -1) led to a significant inhibition by 60%. When B16 cells were pretreated with AS101 for 24 h before injection, the lung metastases were further reduced by subsequent AS101 treatment of the tumor-loaded mice. In mice that had been depleted of natural killer (NK) cells using anti-asialo-GM1 antisera, AS101 was deprived of its stimulatory effect on the NK activity. The inhibition by AS101 on the B16 lung metastasis was also profoundly reduced by the antisera. Moreover, in vitro treatment of B16 cells with AS101 resulted in suppression of the cell growth in a semisolid culture. This was accompanied by an inhibition of the DNA synthesis and a dephosphorylation/activation of the retinoblastoma susceptibility protein (RE), a tumor suppressor gene product, in the B16 cells. Taken together, these data suggest that AS101 possesses an anti-metastatic activity, which probably involves two mechanisms: the stimulation of the host NK cell activity and the inhibition of the tumor cell proliferation.
Authors:
R Xu; Y Kalechman; M Albeck; H Kung; B Sredni
Related Documents :
21242518 - Presentation of acquired peptide-mhc class ii ligands by cd4+ regulatory t cells or hel...
3083688 - Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. immunohisto...
21104978 - Osteoblasts derived from induced pluripotent stem cells form calcified structures in sc...
3113748 - Cytochalasin b enhances t cell mitogenesis by promoting expression of an interleukin 2 ...
20801108 - Diffusible, membrane-bound, and extracellular matrix factors from olfactory ensheathing...
9438208 - Defect in th1-like cells of nonresponders to hepatitis b vaccine.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of oncology     Volume:  9     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  1996 Aug 
Date Detail:
Created Date:  2011-05-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  319-25     Citation Subset:  -    
Affiliation:
BAR ILAN UNIV,DEPT LIFE SCI,CANC AIDS & IMMUNOL RES CTR,IL-52900 RAMAT GAN,ISRAEL.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hematopoietic rescue in mice via alpha 1-adrenoceptors on bone marrow B cell precursors.
Next Document:  Genetics of colorectal cancer (Review).